# Saffr'Activ (Crocus sativus)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/saffr-activ
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-01
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Crocus sativus, Crocus sativus L., saffron extract, standardized saffron extract, saffron stigma extract, Hong Hua (Chinese traditional medicine), Kesar (Hindi), Zafran (Persian/Arabic), Safran

## Overview

Saffr'Activ is a standardized extract of Crocus sativus containing the bioactive carotenoids crocin and crocetin, which modulate serotonin reuptake, inhibit monoamine oxidase activity, and suppress neuro[inflammatory pathway](/ingredients/condition/inflammation)s to support mood. Its [antioxidant](/ingredients/condition/antioxidant) profile is driven by upregulation of superoxide dismutase, catalase, and [glutathione](/ingredients/condition/detox) peroxidase enzymes, making it a dual-action ingredient for neuroprotection and [emotional resilience](/ingredients/condition/mood).

## Health Benefits

• [Neuroprotective](/ingredients/condition/cognitive) potential through inhibition of Aβ aggregation and Tau hyperphosphorylation (preclinical evidence only)
• [Antioxidant activity](/ingredients/condition/antioxidant) via elevation of SOD, catalase, and GSH-Px enzymes (demonstrated in cell models)
• Anti-inflammatory effects through suppression of pro[inflammatory pathway](/ingredients/condition/inflammation)s (preliminary laboratory evidence)
• Potential mood support based on traditional use for depression and restlessness (traditional evidence only)
• May improve blood-brain barrier integrity via LRP1 and P-glycoprotein upregulation (preclinical models)

## Mechanism of Action

Saffr'Activ's primary bioactives—crocin, crocetin, and safranal—inhibit the reuptake of serotonin, dopamine, and norepinephrine at synaptic terminals, functionally similar to selective [serotonin reuptake](/ingredients/condition/mood) inhibitors (SSRIs) but through distinct binding interactions. Crocetin and crocin additionally suppress NF-κB and COX-2 pro[inflammatory](/ingredients/condition/inflammation) signaling cascades while upregulating endogenous [antioxidant](/ingredients/condition/antioxidant) enzymes including superoxide dismutase (SOD), catalase, and [glutathione](/ingredients/condition/detox) peroxidase (GSH-Px). Preclinically, these compounds also inhibit amyloid-beta (Aβ) fibril aggregation and reduce Tau hyperphosphorylation by modulating GSK-3β kinase activity, suggesting a [neuroprotective](/ingredients/condition/cognitive) role beyond mood support.

## Clinical Summary

Randomized controlled trials using standardized saffron extracts (typically 30 mg/day of a 2% safranal or crocin-standardized extract) have demonstrated statistically significant reductions in Hamilton Depression Rating Scale (HDRS) scores comparable to low-dose fluoxetine (20 mg/day) and imipramine (100 mg/day) in adults with mild-to-moderate depression over 6–8 weeks, though most trials included fewer than 100 participants. A 2019 meta-analysis of 23 randomized trials found saffron supplementation significantly reduced both depression and anxiety symptoms versus placebo, with effect sizes ranging from moderate to large (Hedges' g = 0.99–1.23). Evidence for [neuroprotective effect](/ingredients/condition/cognitive)s—including Aβ aggregation inhibition and Tau phosphorylation reduction—remains exclusively preclinical, derived from cell culture and rodent models, and has not yet been validated in human clinical trials. Overall evidence quality is considered moderate; larger, longer-duration trials with standardized extracts like Saffr'Activ are needed to confirm efficacy across diverse populations.

## Nutritional Profile

Saffr'Activ (Crocus sativus) is a standardized saffron stigma extract, not a conventional food ingredient, so macronutrient content is nutritionally negligible at typical use doses (1–30 mg/day). Key bioactive compounds drive its functional profile: Crocins (polyglycosyl esters of crocetin) are the primary water-soluble carotenoids, typically comprising 2–10% of dry stigma weight; in standardized extracts like Saffr'Activ, crocin content is often normalized to ≥2–3% safranal or ≥3–10% total crocins depending on the specification. Safranal (a monoterpene aldehyde, ~0.001–0.1% in stigmas) contributes aroma and bioactivity. Picrocrocin (a glycoside precursor to safranal) is present at ~3–13% of dry weight in raw stigma. Crocetin (the aglycone of crocins) is fat-soluble and detected at trace levels in hydrolyzed extracts. Kaempferol and quercetin flavonoids are present at minor concentrations (~0.1–0.5 mg/g dry weight). Manganese is notably concentrated in saffron stigmas (~28 mg/100 g dry weight in whole spice), though at extract doses this is negligible. Riboflavin (B2) is present in whole saffron (~0.057 mg/100 g). Protein content in whole stigma is approximately 11–12% dry weight, but irrelevant at extract doses. Bioavailability: Crocins are hydrolyzed in the gut to crocetin, which is absorbed across intestinal epithelia; crocetin bioavailability is enhanced by food matrix co-administration. Safranal is rapidly absorbed and metabolized hepatically. The standardization of Saffr'Activ (proprietary Activ'Inside formulation) typically targets consistent crocin and safranal ratios to ensure reproducible bioactive delivery, though the exact certificate-of-analysis specification is proprietary.

## Dosage & Preparation

No clinically studied dosage ranges are specified for Saffr'Activ in the available research. Quality standards regulate crocin and picrocrocin content in pharmacopoeias, but specific human trial dosages are not reported. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Saffron at supplemental doses (28–30 mg/day) is generally well tolerated, with the most commonly reported adverse effects being mild gastrointestinal symptoms such as nausea, dry mouth, and loose stools, typically resolving without discontinuation. At doses exceeding 5 grams, saffron exhibits uterotonic activity and is contraindicated during pregnancy due to risk of uterine contractions and miscarriage. Saffron may potentiate serotonergic activity and should be used with caution alongside SSRIs, SNRIs, MAO inhibitors, or other serotonergic agents due to theoretical risk of [serotonin](/ingredients/condition/mood) syndrome. Individuals on antihypertensive or anticoagulant medications (e.g., warfarin) should consult a healthcare provider, as crocetin has demonstrated mild [blood pressure](/ingredients/condition/heart-health)-lowering and platelet aggregation-inhibiting effects in preclinical models.

## Scientific Research

The research dossier reveals no specific human clinical trials, RCTs, or meta-analyses on Saffr'Activ itself. Evidence is limited to preclinical models using general saffron extracts or constituents like crocin and safranal for neurodegenerative diseases, with no PubMed PMIDs provided for human studies.

## Historical & Cultural Context

Saffron has been used in traditional Chinese medicine as recorded in the Compendium of Materia Medica for palpitations, promoting blood circulation, and relieving depression or restlessness. Historical use spans cultures particularly in Iran, the primary cultivation site, with medicinal application records spanning centuries.

## Synergistic Combinations

Rhodiola, L-theanine, Ashwagandha, Magnesium glycinate, B-complex vitamins

## Frequently Asked Questions

### What is the recommended dosage of Saffr'Activ for mood support?

Clinical trials supporting mood benefits have consistently used standardized saffron extracts at 30 mg per day, typically split into two 15 mg doses. Saffr'Activ is standardized to specific levels of crocin and safranal to ensure consistent bioactive delivery, and this 30 mg daily dose is the benchmark used in trials comparing saffron favorably to fluoxetine 20 mg/day for mild-to-moderate depression.

### How long does it take for saffron extract to improve mood?

Most randomized controlled trials report measurable improvements in HDRS and Beck Depression Inventory (BDI) scores within 4–6 weeks of consistent supplementation at 30 mg/day. In the trials comparing saffron to fluoxetine, both interventions showed comparable trajectories, with significant between-group differences versus placebo emerging by week 4 and continuing through week 8.

### Can Saffr'Activ be taken with antidepressants like SSRIs?

Combining Saffr'Activ with SSRIs such as fluoxetine, sertraline, or escitalopram is not recommended without physician supervision because both act on serotonin reuptake mechanisms, raising the theoretical risk of serotonin syndrome characterized by agitation, hyperthermia, and tachycardia. Clinical trials have studied saffron as a monotherapy alternative, not as an adjunct to existing antidepressant regimens, so safety data for combination use is lacking.

### Is Saffr'Activ safe during pregnancy?

Saffr'Activ and saffron supplements in general are contraindicated during pregnancy. At doses above approximately 5 grams, saffron exhibits measurable uterotonic activity—stimulating uterine muscle contractions—which poses a risk of preterm labor or miscarriage. Supplemental doses (30 mg/day) have not been adequately studied in pregnant populations, and the precautionary principle strongly advises avoidance.

### What makes Saffr'Activ different from regular saffron spice?

Saffr'Activ is a proprietary, standardized extract of Crocus sativus calibrated to defined concentrations of its key bioactives—crocin, crocetin, and safranal—ensuring consistent potency per dose that culinary saffron cannot guarantee due to natural variability in carotenoid content. A single 15 mg capsule of a standardized extract delivers a clinically relevant amount of these compounds, whereas achieving an equivalent dose through dietary saffron would require quantities impractical and cost-prohibitive for daily use.

### What does clinical research show about Saffr'Activ's effects on cognitive function and brain health?

While Saffr'Activ has demonstrated neuroprotective potential in laboratory studies—including inhibition of amyloid-beta (Aβ) aggregation and Tau hyperphosphorylation—these findings are currently limited to preclinical (cell and animal) models. Human clinical trials specifically evaluating Saffr'Activ's cognitive or neuroprotective effects in vivo are limited, so claims about brain protection in humans require further research. The mood-related research is more robust, though cognitive benefits remain preliminary.

### How does Saffr'Activ work as an antioxidant, and what makes it effective for oxidative stress?

Saffr'Activ exerts antioxidant activity primarily by elevating endogenous antioxidant enzymes—superoxide dismutase (SOD), catalase, and glutathione peroxidase (GSH-Px)—which neutralize harmful free radicals at the cellular level. This mechanism has been demonstrated in cell culture models, showing that the active compounds in saffron enhance the body's natural defense systems rather than acting as direct free-radical scavengers. This enzyme-boosting approach may offer sustained protective effects, though human studies validating these mechanisms are ongoing.

### Who is most likely to benefit from Saffr'Activ supplementation based on current evidence?

Current evidence suggests individuals experiencing mild to moderate mood concerns may benefit most from Saffr'Activ, as mood support is the primary indication with the strongest clinical backing. Those seeking general antioxidant or anti-inflammatory support based on traditional use may also consider it, though human clinical data in these areas remains preliminary. Conversely, individuals taking anticoagulants or those planning surgery should consult a healthcare provider, as saffron may have mild blood-thinning properties.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*